436 related articles for article (PubMed ID: 19840668)
21. Purification and cDNA cloning of a novel protease inhibitor secreted into culture supernatant by MDCK cells.
Nishiyama K; Sugawara K; Nouchi T; Kawano N; Soejima K; Abe S; Mizokami H
Biologicals; 2008 Mar; 36(2):122-33. PubMed ID: 17892946
[TBL] [Abstract][Full Text] [Related]
22. Expression of influenza B virus hemagglutinin containing multibasic residue cleavage sites.
Brassard DL; Lamb RA
Virology; 1997 Sep; 236(2):234-48. PubMed ID: 9325231
[TBL] [Abstract][Full Text] [Related]
23. TMPRSS2 and TMPRSS4 facilitate trypsin-independent spread of influenza virus in Caco-2 cells.
Bertram S; Glowacka I; Blazejewska P; Soilleux E; Allen P; Danisch S; Steffen I; Choi SY; Park Y; Schneider H; Schughart K; Pöhlmann S
J Virol; 2010 Oct; 84(19):10016-25. PubMed ID: 20631123
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of influenza virus infection in human airway cell cultures by an antisense peptide-conjugated morpholino oligomer targeting the hemagglutinin-activating protease TMPRSS2.
Böttcher-Friebertshäuser E; Stein DA; Klenk HD; Garten W
J Virol; 2011 Feb; 85(4):1554-62. PubMed ID: 21123387
[TBL] [Abstract][Full Text] [Related]
25. Influenza HA subtypes demonstrate divergent phenotypes for cleavage activation and pH of fusion: implications for host range and adaptation.
Galloway SE; Reed ML; Russell CJ; Steinhauer DA
PLoS Pathog; 2013 Feb; 9(2):e1003151. PubMed ID: 23459660
[TBL] [Abstract][Full Text] [Related]
26. The host protease TMPRSS2 plays a major role in in vivo replication of emerging H7N9 and seasonal influenza viruses.
Sakai K; Ami Y; Tahara M; Kubota T; Anraku M; Abe M; Nakajima N; Sekizuka T; Shirato K; Suzaki Y; Ainai A; Nakatsu Y; Kanou K; Nakamura K; Suzuki T; Komase K; Nobusawa E; Maenaka K; Kuroda M; Hasegawa H; Kawaoka Y; Tashiro M; Takeda M
J Virol; 2014 May; 88(10):5608-16. PubMed ID: 24600012
[TBL] [Abstract][Full Text] [Related]
27. Factors responsible for plaque formation of A/duck/Siberia/272/1998 (H13N6) influenza virus on MDCK cells.
Tsuda Y; Isoda N; Sakoda Y; Kida H
Virus Res; 2009 Mar; 140(1-2):194-8. PubMed ID: 19146891
[TBL] [Abstract][Full Text] [Related]
28. Assays for functional binding of plasminogen to viral proteins.
Goto H; Kawaoka Y
Methods; 2000 Jun; 21(2):159-63. PubMed ID: 10816377
[TBL] [Abstract][Full Text] [Related]
29. Proteolytic activation of the 1918 influenza virus hemagglutinin.
Chaipan C; Kobasa D; Bertram S; Glowacka I; Steffen I; Tsegaye TS; Takeda M; Bugge TH; Kim S; Park Y; Marzi A; Pöhlmann S
J Virol; 2009 Apr; 83(7):3200-11. PubMed ID: 19158246
[TBL] [Abstract][Full Text] [Related]
30. Aprotinin and similar protease inhibitors as drugs against influenza.
Zhirnov OP; Klenk HD; Wright PF
Antiviral Res; 2011 Oct; 92(1):27-36. PubMed ID: 21802447
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of chicken-origin (DF-1) and quail-origin (QT-6) fibroblast cell lines for replication of avian influenza viruses.
Lee CW; Jung K; Jadhao SJ; Suarez DL
J Virol Methods; 2008 Oct; 153(1):22-8. PubMed ID: 18638503
[TBL] [Abstract][Full Text] [Related]
32. Role of hemagglutinin cleavage for the pathogenicity of influenza virus.
Steinhauer DA
Virology; 1999 May; 258(1):1-20. PubMed ID: 10329563
[TBL] [Abstract][Full Text] [Related]
33. Non-human primate orthologues of TMPRSS2 cleave and activate the influenza virus hemagglutinin.
Zmora P; Molau-Blazejewska P; Bertram S; Walendy-Gnirß K; Nehlmeier I; Hartleib A; Moldenhauer AS; Konzok S; Dehmel S; Sewald K; Brinkmann C; Curths C; Knauf S; Gruber J; Mätz-Rensing K; Dahlmann F; Braun A; Pöhlmann S
PLoS One; 2017; 12(5):e0176597. PubMed ID: 28493964
[TBL] [Abstract][Full Text] [Related]
34. Establishment of MDCK Stable Cell Lines Expressing TMPRSS2 and MSPL and Their Applications in Propagating Influenza Vaccine Viruses in Absence of Exogenous Trypsin.
Wen Z; Wu C; Chen W; Zeng X; Shi J; Ge J; Chen H; Bu Z
Biotechnol Res Int; 2015; 2015():402628. PubMed ID: 25918647
[TBL] [Abstract][Full Text] [Related]
35. Structural and evolutionary characteristics of HA, NA, NS and M genes of clinical influenza A/H3N2 viruses passaged in human and canine cells.
Zhirnov OP; Vorobjeva IV; Saphonova OA; Poyarkov SV; Ovcharenko AV; Anhlan D; Malyshev NA
J Clin Virol; 2009 Aug; 45(4):322-33. PubMed ID: 19546028
[TBL] [Abstract][Full Text] [Related]
36. Cell tropism of influenza virus mediated by hemagglutinin activation at the stage of virus entry.
Boycott R; Klenk HD; Ohuchi M
Virology; 1994 Sep; 203(2):313-9. PubMed ID: 8053155
[TBL] [Abstract][Full Text] [Related]
37. Matriptase proteolytically activates influenza virus and promotes multicycle replication in the human airway epithelium.
Beaulieu A; Gravel É; Cloutier A; Marois I; Colombo É; Désilets A; Verreault C; Leduc R; Marsault É; Richter MV
J Virol; 2013 Apr; 87(8):4237-51. PubMed ID: 23365447
[TBL] [Abstract][Full Text] [Related]
38. Establishment of a genetically engineered chicken DF-1 cell line for efficient amplification of influenza viruses in the absence of trypsin.
Chungu K; Park YH; Woo SJ; Lee SB; Rengaraj D; Lee HJ; Han JY
BMC Biotechnol; 2021 Jan; 21(1):2. PubMed ID: 33413322
[TBL] [Abstract][Full Text] [Related]
39. TMPRSS11A activates the influenza A virus hemagglutinin and the MERS coronavirus spike protein and is insensitive against blockade by HAI-1.
Zmora P; Hoffmann M; Kollmus H; Moldenhauer AS; Danov O; Braun A; Winkler M; Schughart K; Pöhlmann S
J Biol Chem; 2018 Sep; 293(36):13863-13873. PubMed ID: 29976755
[TBL] [Abstract][Full Text] [Related]
40. TMPRSS2 Independency for Haemagglutinin Cleavage In Vivo Differentiates Influenza B Virus from Influenza A Virus.
Sakai K; Ami Y; Nakajima N; Nakajima K; Kitazawa M; Anraku M; Takayama I; Sangsriratanakul N; Komura M; Sato Y; Asanuma H; Takashita E; Komase K; Takehara K; Tashiro M; Hasegawa H; Odagiri T; Takeda M
Sci Rep; 2016 Jul; 6():29430. PubMed ID: 27389476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
